Cargando…

OCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast Cancer

The cancer stem cell (CSC) hypothesis proposes that CSCs are responsible for metastasis and disease recurrence. Therefore, targeting CSCs has the potential to significantly improve outcomes for cancer patients. The OCT4 transcription factor gene is a master gene that plays a key role in the self-ren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ran-Ju, Nam, Jeong-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for Laboratory Animal Science 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145994/ https://www.ncbi.nlm.nih.gov/pubmed/21826175 http://dx.doi.org/10.5625/lar.2011.27.2.147

Ejemplares similares

Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line
por: Park, Se-Jin, et al.
Publicado: (2011)

Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency
por: Choi, Hyun Woo, et al.
Publicado: (2016)

Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
por: Gwak, Jae Moon, et al.
Publicado: (2017)

Post-translational modification of OCT4 in breast cancer tumorigenesis
por: Cho, Yunhee, et al.
Publicado: (2018)

The Flavonoid Glabridin Induces OCT4 to Enhance Osteogenetic Potential in Mesenchymal Stem Cells
por: Heo, June Seok, et al.
Publicado: (2017)

Cell-Permeable Oct4 Gene Delivery Enhances Stem Cell-like Properties of Mouse Embryonic Fibroblasts
por: Choi, Da Hyeon, et al.
Publicado: (2021)

Hyperthermia depletes Oct4 in mouse blastocysts and stem cells
por: Cheng, Mo-bin, et al.
Publicado: (2020)

Species-Specific Enhancer Activity of OCT4 in Porcine Pluripotency: The Porcine OCT4 Reporter System Could Monitor Pluripotency in Porcine Embryo Development and Embryonic Stem Cells
por: Kim, Seung-Hun, et al.
Publicado: (2022)

Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
por: Chen, Fei, et al.
Publicado: (2020)

MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels
por: Närvä, Elisa, et al.
Publicado: (2022)

Pontin functions as an essential coactivator for Oct4-dependent lincRNA expression in mouse embryonic stem cells
por: Boo, Kyungjin, et al.
Publicado: (2015)

Phenotypical and ultrastructural features of Oct4-positive cells in the adult mouse lung
por: Galiger, Celimene, et al.
Publicado: (2014)

NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification
por: Yang, Yongkang, et al.
Publicado: (2022)

The ontogeny of myometrial stem cells in OCT4-GFP transgenic mouse model
por: Brakta, Soumia, et al.
Publicado: (2018)

NFATc3 plays an oncogenic role in oral/oropharyngeal squamous cell carcinomas by promoting cancer stemness via expression of OCT4
por: Lee, Sung Hee, et al.
Publicado: (2019)

Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2014)

Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression
por: Redshaw, Zoe, et al.
Publicado: (2010)

Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer
por: You, Liuping, et al.
Publicado: (2018)

Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary
por: Samardzija, Chantel, et al.
Publicado: (2012)

Changes in the expression of OCT4 in mouse ovary during estrous cycle
por: Bagheripour, Narges, et al.
Publicado: (2017)

Expression of OCT4 isoforms is reduced in primary colorectal cancer
por: Turyova, Eva, et al.
Publicado: (2023)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2021)

Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
por: Chen, Yu-Chih, et al.
Publicado: (2008)

Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
por: Kim, Bo Wook, et al.
Publicado: (2015)

Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
por: Kumar, Suresh M., et al.
Publicado: (2012)

Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells
por: Cheng, Jie, et al.
Publicado: (2015)

The Role and Specific Mechanism of OCT4 in Cancer Stem Cells: A Review
por: Zhang, Qi, et al.
Publicado: (2020)

OCT4 Expression and Vasculogenic Mimicry Formation Positively Correlate with Poor Prognosis in Human Breast Cancer
por: Liu, Tieju, et al.
Publicado: (2014)

The roles of long noncoding RNAs in the regulation of OCT4 expression
por: Zhou, Rui-Ting, et al.
Publicado: (2022)

A Novel Variant of OCT4 Entitled OCT4B3 is Expressed in Human Bladder Cancer and Astrocytoma Cell Lines
por: Poursani, Ensieh M., et al.
Publicado: (2017)

Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer
por: Hong, Liwei, et al.
Publicado: (2023)

PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
por: Almozyan, Sheema, et al.
Publicado: (2017)

Akt-mediated phosphorylation of Oct4 is associated with the proliferation of stem-like cancer cells
por: ZHAO, QING-WEI, et al.
Publicado: (2015)

Oct4 differentially regulates chromatin opening and enhancer transcription in pluripotent stem cells
por: Xiong, Le, et al.
Publicado: (2022)

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

OCT4 interprets and enhances nucleosome flexibility
por: MacCarthy, Caitlin M, et al.
Publicado: (2022)

Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes
por: Hu, Jun, et al.
Publicado: (2017)

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018)

Reduced Oct4 Expression Directs a Robust Pluripotent State with Distinct Signaling Activity and Increased Enhancer Occupancy by Oct4 and Nanog
por: Karwacki-Neisius, Violetta, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0mjsru01qs22740sl0sconj6jv